Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
GLP-1 agonists (exenatide and liraglutide) and DPP-4 inhibitors (sitagliptin, vildagliptin, saxagliptin and linagliptin) currently represent effective treatment options for patients with type 2 diabetes
The risk of nonarteritic anterior ischemic optic neuropathy (NAION) was not significantly different among those on GLP-1 drugs and those on other diabetes medicines
Kolodziejczyk J, Saluk-Juszczak J, Wachowicz B, Elsevier (2011) L-Carnitine protects plasma components against oxidative alterations
Baseline patient characteristics, full frequencies of side effects and study structure are not described in detail
That's why you've got to move into the second phase
US$ 29.75
US$ 21.55
US$ 28.32
US$ 29.59
US$ 26.19
US$ 25.82
